MedImmune , Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results

Oct. 4 /PRNewswire/ -- MedImmune, Inc. announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annual Meeting adding to the body of knowledge about respiratory syncytial virus* (RSV). RSV is a viral pathogen that produces annual outbreaks usually between fall and spring. While RSV typically manifests cold-like symptoms in healthy children, it can prove to be a very serious respiratory illness for premature infants and is the leading cause of respiratory infections for newborns each year... MedImmune 's Press Release -